| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 08/22/2006 | US7094772 Phosphonate compounds |
| 08/22/2006 | US7094757 diagnosis of transmissible spongiform encephalopathies (TSEs) especially in an immunoassay, as well as its use as an immunogen; genetic engineering |
| 08/22/2006 | US7094750 Toxin for use in treating cancer; antitumor agents |
| 08/22/2006 | US7094577 Insulin and albumin fusion protein |
| 08/22/2006 | US7094550 Diagnosing atherosclerosis in humans; obtain blood, incubate with confining complex, detect signal from bound complex, evaluate for atherosclerosis |
| 08/22/2006 | US7094425 Enteric and colonic delivery using HPMC capsules |
| 08/22/2006 | US7094424 Cationic lipid compositions targeting angiogenic endothelial cells |
| 08/22/2006 | US7094422 With dermal penetration enhancer, octyl salicylate |
| 08/22/2006 | US7094421 Plaster containing 4-biphenylacetic acid |
| 08/22/2006 | US7094420 Methods of using isomer enriched conjugated linoleic acid compositions |
| 08/22/2006 | US7094419 from an implantable immunomodulation device having an impermeable, yet porous, biocompatible outer shell and an inner lumen of a fibrous scaffolding having an antigen or chemotatic agent sufficient to provoke an immune response |
| 08/22/2006 | US7094415 And emollient and humectant, colostrum, lactoferrin and/or methyl sulfonyl methane; soothing sore muscles, expediting healing and repairing of skin and reducing visual appearance of cellulite |
| 08/22/2006 | US7094414 Famotidine injections |
| 08/22/2006 | US7094412 Poxvirus containing formulations and process for preparing stable poxvirus containing compositions |
| 08/22/2006 | US7094409 Antigen arrays for treatment of allergic eosinophilic diseases |
| 08/22/2006 | US7094392 Heating antihistamine drug vaporize; cooling to form a condensation aerosol; kit for dispensing thin coating |
| 08/22/2006 | CA2368138C Mechanically stable pharmaceutical presentation form containing liquid or semisolid surface-active substances |
| 08/22/2006 | CA2231719C Microemulsion |
| 08/22/2006 | CA2229614C The production of solid combination drug forms |
| 08/22/2006 | CA2214979C Improvements in or relating to organic compositions |
| 08/22/2006 | CA2207334C Sustained-release granular preparations and production process thereof |
| 08/22/2006 | CA2118792C Immunopotentiating and infection protective agent and production thereof |
| 08/18/2006 | CA2498623A1 Treatment of onychomycosis |
| 08/17/2006 | WO2006086733A2 Process for preparing maytansinoid antibody conjugates |
| 08/17/2006 | WO2006086303A1 Method for the mitigation of symptoms of contact lens related dry eye |
| 08/17/2006 | WO2006086038A1 Methods and related compositions for reduction of fat and skin tightening |
| 08/17/2006 | WO2006085747A1 Controlled release compositions for interferon based on pegt/pbt block copolymers |
| 08/17/2006 | WO2006085664A1 Polycation chargeable polymer and use as carrier of nucleic acid |
| 08/17/2006 | WO2006085655A1 Ointment |
| 08/17/2006 | WO2006085653A1 Hydrogel for medical use |
| 08/17/2006 | WO2006085583A1 Cell permeable peptide |
| 08/17/2006 | WO2006085521A1 Medicinal composition for transdermal absorption containing opipid receptor antagonist, method of producing the same and method of promoting the transdermal absorption of the antagonist |
| 08/17/2006 | WO2006085517A1 Ointment preparation or suppository for pdt based on chlorin or porphyrin derivative |
| 08/17/2006 | WO2006085516A1 Support for protein transfer, protein transfer agent using the support, protein transfer method, cell having protein transferred thereinto and method of producing the same |
| 08/17/2006 | WO2006085497A1 Tablet disintegrating in the oral cavity |
| 08/17/2006 | WO2006085336A2 Stabilized anthracycline glycoside pharmaceutical compositions |
| 08/17/2006 | WO2006085335A2 Pharmaceutical composition of acid labile substances |
| 08/17/2006 | WO2006085143A2 Improved bioactive agent compositions for repair of cell injuries |
| 08/17/2006 | WO2006084902A2 Method of purifying a surfactant by ultrafiltration |
| 08/17/2006 | WO2006084888A2 C-terminally pegylated growth hormones |
| 08/17/2006 | WO2006084842A1 Process for the preparation of alkoxyamine functionalised polyethylene glycols |
| 08/17/2006 | WO2006084782A1 Use of iron(iii) complex compounds |
| 08/17/2006 | WO2006084547A1 Compositions containing biguanide |
| 08/17/2006 | WO2006084353A1 Stabilized compositions for topical administration and methods of making same |
| 08/17/2006 | WO2006084339A1 Layered nanoparticles |
| 08/17/2006 | WO2006065861A3 Therapeutic formulations of keratinocyte growth factor |
| 08/17/2006 | WO2006061650A3 Methods, products and uses involving platelets and/or the vasculature |
| 08/17/2006 | WO2006058248A9 Methods for increasing the immune response in an animal |
| 08/17/2006 | WO2006058248A2 Methods for increasing the immune response in an animal |
| 08/17/2006 | WO2006054315B1 Nonaqueous liquid parenteral aceclofenac formulation |
| 08/17/2006 | WO2006038110A3 Amphiphilic star block copolymers |
| 08/17/2006 | WO2006025767A3 Perorally administrable antimicrobial composition |
| 08/17/2006 | WO2006023645A3 Aesthetic use of hyaluronan |
| 08/17/2006 | WO2006007412B1 Peptide yy formulations having increased stability and resistance to microbial agents |
| 08/17/2006 | WO2005112977A3 Compositions for treatment with glucagon-like peptide, and methods of making and using the same |
| 08/17/2006 | WO2005111224A8 Water-soluble coenzyme q10 in inclusion complex with beta-cyclodextrin, process of preparing, and use thereof |
| 08/17/2006 | WO2005107723A3 Transdermal delivery systems and transdermal chelation preparations |
| 08/17/2006 | WO2005097201A3 Inclusion complexes containing piroxicam, a cyclodextrin and arginine |
| 08/17/2006 | WO2005097058A3 Cyclodextrin inclusions complexes of pyrimidine-2,4,6-triones |
| 08/17/2006 | WO2003087124A3 Hmgn2 peptides and related melecules that selectively home to tumor blood vessels and tumor cells |
| 08/17/2006 | US20060184158 Osmotic delivery system with early zero order push power engine |
| 08/17/2006 | US20060183886 Ligands to enhance cellular uptake of biomolecules |
| 08/17/2006 | US20060183855 Used to make drug polymer conjugates, high and low molecular weight segments of for example, polyethylene glycol, linked together via amide, a carbamate, an ester, a urea, an amine, a thioether, or a disulfide linkage |
| 08/17/2006 | US20060183722 Formulation for lipophilic agents |
| 08/17/2006 | US20060183714 3-Alpha-glycosyl alpha, alpha-trehalose compound, process for producing the same, and use |
| 08/17/2006 | US20060183713 Compositions of low molecular weight heparin produced with modified heparinase III |
| 08/17/2006 | US20060183697 Complexing of medicinal substances with high-molecular carriers and injection and infusion solutions containing said complexes |
| 08/17/2006 | US20060183689 Activation of peptide prodrugs by hK2 |
| 08/17/2006 | US20060183685 Peptide pharmaceutical formulations |
| 08/17/2006 | US20060183683 Liquid composition of factor VII polypeptides |
| 08/17/2006 | US20060183680 Remedy for ischemia |
| 08/17/2006 | US20060183679 Peptides having a high cysteine content |
| 08/17/2006 | US20060182820 Homogeneous Dispersions Containing Citrus Pulp and Applications Thereof |
| 08/17/2006 | US20060182813 Colloidal silver composition having microbial properties |
| 08/17/2006 | US20060182810 Microencapsulated 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles |
| 08/17/2006 | US20060182809 System for transporting active substances in a biological system |
| 08/17/2006 | US20060182807 Copolymer and hemoprotein based novel compounds and uses thereof |
| 08/17/2006 | US20060182802 Rapidly disintegrable solid preparation |
| 08/17/2006 | US20060182795 containing a polymer, a therapeutic agent, and a complexing agent, where the polymer interacts with the complexing agent in a host-guest or a guest-host interaction to form an inclusion complex; may be used to deliver a therapeutic agent in treatment of various disorders |
| 08/17/2006 | US20060182784 Protein hydrolysate and plant sterol containing composition for improving serum lipid profile and preventing atherosclerosis |
| 08/17/2006 | US20060182753 Vaccines |
| 08/17/2006 | US20060182746 Binding to monoclonal antibody; antitumor agents |
| 08/17/2006 | US20060182740 Buffered formulations for concentrating antibodies and methods of use thereof |
| 08/17/2006 | US20060182735 Thrombin preparations and process for their production |
| 08/17/2006 | US20060182734 Contacting polysaccharide with disaccharide repeat unit of uronic acid [ alpha -L-iduronic acid or beta -D-glucuronic acid ] linked 1, 4 to alpha -D-hexosamine with mutant heparinase III; sequencing mucopolysaccharides; antitumor, anticarcinogenic and antimetastasis agents; angiogenesis inhibitors |
| 08/17/2006 | US20060182715 Therapies for chronic inflammatory demyelinating polyneuropathy using interferon-ss |
| 08/17/2006 | US20060182692 Drugs covalently attached to a a hydrophilic polymer such as monomethoxy polyethylene glycol; pharmacokinetics; reduced first pass effect; side effect reduction; dosage forms; inhalers |
| 08/17/2006 | US20060182688 Metronidazole-based tinted topical pharmaceutical compositions |
| 08/17/2006 | US20060182683 Methods for reduced renal uptake of protein conjugates |
| 08/17/2006 | DE102005005573A1 Hydrophiles Gelsystem zur Hautpflege auf Basis von Karaya-Gummi Hydrophilic gel system for skin care on the basis of karaya gum |
| 08/17/2006 | DE102005003708A1 Skin care oil, useful as massage oil, for preparing cosmetics to reduce, treat and/or prevent scar tissue, scaly skin, skin stretch marks, skin moisturizing and increasing blood circulation in skin, comprises cocoa butter and jojoba oil |
| 08/17/2006 | DE10159120B4 Steroidhormonhaltige transdermale therapeutische Systeme enthaltend Propylenglycolmonocaprylat und seine Verwendung Steroid hormone-containing transdermal therapeutic systems containing Propylenglycolmonocaprylat and its use |
| 08/17/2006 | CA2598558A1 Layered nanoparticles |
| 08/17/2006 | CA2597583A1 Support for protein transfer, protein transfer agent using the support, protein transfer method, cell having protein transferred thereinto and method of producing the same |
| 08/17/2006 | CA2597537A1 Ointment |
| 08/17/2006 | CA2597407A1 Process for preparing stable drug conjugates |
| 08/17/2006 | CA2597378A1 Synthesis of homopolymers and block copolymers |
| 08/17/2006 | CA2597346A1 A molecule and chimeric molecules thereof |
| 08/17/2006 | CA2597223A1 Method of purifying a surfactant by ultrafiltration |
| 08/17/2006 | CA2596876A1 Method for the mitigation of symptoms of contact lens related dry eye |